Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome

Universitätsklinikum Köln

Status: Completed

Conditions: Cardiac Arrest

Study type: Observational

Funder types: Other

Identifiers

NCT02247947

14-053

Details and patient eligibility

About

Proteomics is used to identify prognostic markers after CPR. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.

Full description

Proteomics is used to identify prognostic markers after CPR, i.e. altered proteins on a 2G-gel. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.

Enrollment: 20 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• cardiac arrest

Exclusion criteria

• trauma

Trial design

20 participants in 2 patient groups

dead

Description:

Patients dead until day 20 (primary outcome measure)

survivors

Description:

patients alive after day 20 (primary outcome measure)